Literature DB >> 2433281

Arg-Gly-Asp recognition by a cell adhesion receptor requires its 130-kDa alpha subunit.

D A Cheresh, J R Harper.   

Abstract

A major Arg-Gly-Asp-directed receptor on M21 human melanoma cells is a heterodimer of alpha and beta chains which under reducing conditions have molecular masses of 130 and 105 kDa, respectively. This receptor is one member of a large family of cell adhesion receptors that shares antigenic determinants with the vitronectin receptor of fibroblasts and the platelet IIb X IIIa complex. Both subunits of the M21 cell adhesion receptor acquire high mannose-type oligosaccharides that are processed before transport to the cell surface. In addition, the alpha chain undergoes a proteolytic cleavage step. Pulse-chase immunoprecipitation analysis demonstrates that, following its synthesis, the beta chain remains unbound to alpha chain for 1-2 h and in this free form is unable to bind an Arg-Gly-Asp containing heptapeptide. Conversely, the biosynthetic precursor of the alpha chain is fully capable of binding the Arg-Gly-Asp-containing peptide immediately after its synthesis. Thus, Arg-Gly-Asp recognition by one member of this cell adhesion receptor family requires its 130-kDa alpha chain which appears to be functional prior to post-translational modifications.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433281

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Integrin expression in human melanoma cells with differing invasive and metastatic properties.

Authors:  K R Gehlsen; G E Davis; P Sriramarao
Journal:  Clin Exp Metastasis       Date:  1992-03       Impact factor: 5.150

Review 2.  Vitronectin receptor: tissue specific expression or adaptation to culture?

Authors:  M Horton
Journal:  Int J Exp Pathol       Date:  1990-10       Impact factor: 1.925

3.  Comparative study of the glycosylation of platelet glycoprotein GPIIb/IIIa and the vitronectin receptor. Differential processing of their beta-subunit.

Authors:  A Troesch; A Duperray; B Polack; G Marguerie
Journal:  Biochem J       Date:  1990-05-15       Impact factor: 3.857

4.  Distinct mechanism of human neuroblastoma cell adhesion to fibronectin.

Authors:  T Yoshihara; S Ikushima; Y Shimizu; N Esumi; S Todo; M J Humphries; S Imashuku
Journal:  Clin Exp Metastasis       Date:  1991 Jul-Aug       Impact factor: 5.150

5.  Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery.

Authors:  Kathryn C Partlow; Gregory M Lanza; Samuel A Wickline
Journal:  Biomaterials       Date:  2008-05-16       Impact factor: 12.479

6.  Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor.

Authors:  D A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.

Authors:  Jianquan Yang; Haixun Guo; Yubin Miao
Journal:  Nucl Med Biol       Date:  2010-07-24       Impact factor: 2.408

8.  Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells.

Authors:  S Klein; F G Giancotti; M Presta; S M Albelda; C A Buck; D B Rifkin
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

9.  Role of the beta-subunit arginine/lysine finger in integrin heterodimer formation and function.

Authors:  Vineet Gupta; José Luis Alonso; Takashi Sugimori; Makram Essafi; Makram Issafi; Jiang-Ping Xiong; M Amin Arnaout
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

10.  Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.

Authors:  G K Koukoulis; I Virtanen; M Korhonen; L Laitinen; V Quaranta; V E Gould
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.